Angioimmunoblastic lymphadenopathy with dysproteinemia - Lack of a prognostic value of clear cell morphology

Hui Ju Ch'ang, Ih Jen Su, Chi Long Chen, I. Pieng Chiang, Yao Chang Chen, Chiu Hwa Wang, Ann Lii Cheng

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

It has been suggested that angioimmunoblastic lymphadenopathy with dysproteinemia (AILD) is closely related to peripheral T cell lymphoma (PTCL). However, the clinical course of AILD-like PTCL is notoriously unpredictable. A minor portion of patients enjoyed prolonged remission with steroid-only treatments (indolent AILD) while most others died rapidly despite the use of intensive chemotherapy (aggressive AILD). Recently, it has been suggested that histological features such as the presence or absence of clear cells and convoluted cells are of high prognostic value. The validity of this observation was addressed in this study. Eighteen patients who presented between 1977 and 1994 at the National Taiwan University Hospital were retrospectively studied. There were 11 men and 7 women, with a median age of 47 years. Twelve patients had received various regimens of systemic chemotherapy, and the other 3 patients had been treated with steroids alone. Eight patients had indolent AILD and 6 aggressive AILD. The follow-up period in 4 patients was too short to be analyzed. The histopathology of these cases was divided, according to the criteria of Aozasa et al., into group I (neither cells), 4 patients; group II (only convoluted cells), 1 patient, and group III (clear cells with or without convoluted cells), 13 patients. Contrary to others, our data revealed that group III patients were doing better than group I patients. Univariate analysis of other pertinent clinical features, including sex, age, lymphadenopathy, B symptoms, hepatosplenomegaly, hypergammaglobulinemia, elevated serum lactate dehydrogenase, and treatment regimens, revealed none of them to be prognostically relevant. However, patients who had achieved complete remission by steroids or other systemic chemotherapy had a significantly better prognosis than those who had not. Together, these preliminary data suggested that (1) the presence or absence of clear cells and convoluted cells failed to predict the clinical behavior; and (2) induction of complete remission by steroids or other chemotherapeutic agents is an important prognostic index.

Original languageEnglish
Pages (from-to)193-198
Number of pages6
JournalOncology
Volume54
Issue number3
Publication statusPublished - May 1997
Externally publishedYes

Fingerprint

Immunoblastic Lymphadenopathy
Steroids
Peripheral T-Cell Lymphoma
Drug Therapy
Hypergammaglobulinemia
Remission Induction
Taiwan
L-Lactate Dehydrogenase

Keywords

  • Angioimmunoblastic lymphadenopathy
  • Clear cell
  • Convoluted cell
  • Dysproteinemia
  • Peripheral T cell lymphoma

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Ch'ang, H. J., Su, I. J., Chen, C. L., Chiang, I. P., Chen, Y. C., Wang, C. H., & Cheng, A. L. (1997). Angioimmunoblastic lymphadenopathy with dysproteinemia - Lack of a prognostic value of clear cell morphology. Oncology, 54(3), 193-198.

Angioimmunoblastic lymphadenopathy with dysproteinemia - Lack of a prognostic value of clear cell morphology. / Ch'ang, Hui Ju; Su, Ih Jen; Chen, Chi Long; Chiang, I. Pieng; Chen, Yao Chang; Wang, Chiu Hwa; Cheng, Ann Lii.

In: Oncology, Vol. 54, No. 3, 05.1997, p. 193-198.

Research output: Contribution to journalArticle

Ch'ang, HJ, Su, IJ, Chen, CL, Chiang, IP, Chen, YC, Wang, CH & Cheng, AL 1997, 'Angioimmunoblastic lymphadenopathy with dysproteinemia - Lack of a prognostic value of clear cell morphology', Oncology, vol. 54, no. 3, pp. 193-198.
Ch'ang, Hui Ju ; Su, Ih Jen ; Chen, Chi Long ; Chiang, I. Pieng ; Chen, Yao Chang ; Wang, Chiu Hwa ; Cheng, Ann Lii. / Angioimmunoblastic lymphadenopathy with dysproteinemia - Lack of a prognostic value of clear cell morphology. In: Oncology. 1997 ; Vol. 54, No. 3. pp. 193-198.
@article{a5233bb963624365bbc0803864c4a393,
title = "Angioimmunoblastic lymphadenopathy with dysproteinemia - Lack of a prognostic value of clear cell morphology",
abstract = "It has been suggested that angioimmunoblastic lymphadenopathy with dysproteinemia (AILD) is closely related to peripheral T cell lymphoma (PTCL). However, the clinical course of AILD-like PTCL is notoriously unpredictable. A minor portion of patients enjoyed prolonged remission with steroid-only treatments (indolent AILD) while most others died rapidly despite the use of intensive chemotherapy (aggressive AILD). Recently, it has been suggested that histological features such as the presence or absence of clear cells and convoluted cells are of high prognostic value. The validity of this observation was addressed in this study. Eighteen patients who presented between 1977 and 1994 at the National Taiwan University Hospital were retrospectively studied. There were 11 men and 7 women, with a median age of 47 years. Twelve patients had received various regimens of systemic chemotherapy, and the other 3 patients had been treated with steroids alone. Eight patients had indolent AILD and 6 aggressive AILD. The follow-up period in 4 patients was too short to be analyzed. The histopathology of these cases was divided, according to the criteria of Aozasa et al., into group I (neither cells), 4 patients; group II (only convoluted cells), 1 patient, and group III (clear cells with or without convoluted cells), 13 patients. Contrary to others, our data revealed that group III patients were doing better than group I patients. Univariate analysis of other pertinent clinical features, including sex, age, lymphadenopathy, B symptoms, hepatosplenomegaly, hypergammaglobulinemia, elevated serum lactate dehydrogenase, and treatment regimens, revealed none of them to be prognostically relevant. However, patients who had achieved complete remission by steroids or other systemic chemotherapy had a significantly better prognosis than those who had not. Together, these preliminary data suggested that (1) the presence or absence of clear cells and convoluted cells failed to predict the clinical behavior; and (2) induction of complete remission by steroids or other chemotherapeutic agents is an important prognostic index.",
keywords = "Angioimmunoblastic lymphadenopathy, Clear cell, Convoluted cell, Dysproteinemia, Peripheral T cell lymphoma",
author = "Ch'ang, {Hui Ju} and Su, {Ih Jen} and Chen, {Chi Long} and Chiang, {I. Pieng} and Chen, {Yao Chang} and Wang, {Chiu Hwa} and Cheng, {Ann Lii}",
year = "1997",
month = "5",
language = "English",
volume = "54",
pages = "193--198",
journal = "Oncology",
issn = "0030-2414",
publisher = "UBM Medica Healthcare Publications",
number = "3",

}

TY - JOUR

T1 - Angioimmunoblastic lymphadenopathy with dysproteinemia - Lack of a prognostic value of clear cell morphology

AU - Ch'ang, Hui Ju

AU - Su, Ih Jen

AU - Chen, Chi Long

AU - Chiang, I. Pieng

AU - Chen, Yao Chang

AU - Wang, Chiu Hwa

AU - Cheng, Ann Lii

PY - 1997/5

Y1 - 1997/5

N2 - It has been suggested that angioimmunoblastic lymphadenopathy with dysproteinemia (AILD) is closely related to peripheral T cell lymphoma (PTCL). However, the clinical course of AILD-like PTCL is notoriously unpredictable. A minor portion of patients enjoyed prolonged remission with steroid-only treatments (indolent AILD) while most others died rapidly despite the use of intensive chemotherapy (aggressive AILD). Recently, it has been suggested that histological features such as the presence or absence of clear cells and convoluted cells are of high prognostic value. The validity of this observation was addressed in this study. Eighteen patients who presented between 1977 and 1994 at the National Taiwan University Hospital were retrospectively studied. There were 11 men and 7 women, with a median age of 47 years. Twelve patients had received various regimens of systemic chemotherapy, and the other 3 patients had been treated with steroids alone. Eight patients had indolent AILD and 6 aggressive AILD. The follow-up period in 4 patients was too short to be analyzed. The histopathology of these cases was divided, according to the criteria of Aozasa et al., into group I (neither cells), 4 patients; group II (only convoluted cells), 1 patient, and group III (clear cells with or without convoluted cells), 13 patients. Contrary to others, our data revealed that group III patients were doing better than group I patients. Univariate analysis of other pertinent clinical features, including sex, age, lymphadenopathy, B symptoms, hepatosplenomegaly, hypergammaglobulinemia, elevated serum lactate dehydrogenase, and treatment regimens, revealed none of them to be prognostically relevant. However, patients who had achieved complete remission by steroids or other systemic chemotherapy had a significantly better prognosis than those who had not. Together, these preliminary data suggested that (1) the presence or absence of clear cells and convoluted cells failed to predict the clinical behavior; and (2) induction of complete remission by steroids or other chemotherapeutic agents is an important prognostic index.

AB - It has been suggested that angioimmunoblastic lymphadenopathy with dysproteinemia (AILD) is closely related to peripheral T cell lymphoma (PTCL). However, the clinical course of AILD-like PTCL is notoriously unpredictable. A minor portion of patients enjoyed prolonged remission with steroid-only treatments (indolent AILD) while most others died rapidly despite the use of intensive chemotherapy (aggressive AILD). Recently, it has been suggested that histological features such as the presence or absence of clear cells and convoluted cells are of high prognostic value. The validity of this observation was addressed in this study. Eighteen patients who presented between 1977 and 1994 at the National Taiwan University Hospital were retrospectively studied. There were 11 men and 7 women, with a median age of 47 years. Twelve patients had received various regimens of systemic chemotherapy, and the other 3 patients had been treated with steroids alone. Eight patients had indolent AILD and 6 aggressive AILD. The follow-up period in 4 patients was too short to be analyzed. The histopathology of these cases was divided, according to the criteria of Aozasa et al., into group I (neither cells), 4 patients; group II (only convoluted cells), 1 patient, and group III (clear cells with or without convoluted cells), 13 patients. Contrary to others, our data revealed that group III patients were doing better than group I patients. Univariate analysis of other pertinent clinical features, including sex, age, lymphadenopathy, B symptoms, hepatosplenomegaly, hypergammaglobulinemia, elevated serum lactate dehydrogenase, and treatment regimens, revealed none of them to be prognostically relevant. However, patients who had achieved complete remission by steroids or other systemic chemotherapy had a significantly better prognosis than those who had not. Together, these preliminary data suggested that (1) the presence or absence of clear cells and convoluted cells failed to predict the clinical behavior; and (2) induction of complete remission by steroids or other chemotherapeutic agents is an important prognostic index.

KW - Angioimmunoblastic lymphadenopathy

KW - Clear cell

KW - Convoluted cell

KW - Dysproteinemia

KW - Peripheral T cell lymphoma

UR - http://www.scopus.com/inward/record.url?scp=0030993851&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030993851&partnerID=8YFLogxK

M3 - Article

VL - 54

SP - 193

EP - 198

JO - Oncology

JF - Oncology

SN - 0030-2414

IS - 3

ER -